ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36685
0.00%
Bitcoin
63,467.10
-0.67%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) News

SLNO Soleno Therapeutics Inc

45.12
-4.11 (-8.35%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Soleno Therapeutics Inc SLNO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-4.11 -8.35% 45.12 17:14:04
Open Price Low Price High Price Close Price Previous Close
47.14 44.98 48.49 45.12 49.23
more quote information »

Recent News

Date Time Source Heading
5/02/202421:32GLOBESoleno Therapeutics Announces Pricing of Approximately $138..
5/02/202415:01GLOBESoleno Therapeutics Announces Proposed Public Offering of..
4/30/202407:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
4/29/202407:00GLOBESoleno Therapeutics Receives Breakthrough Therapy..
4/19/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
3/08/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
3/07/202405:06EDGAR2Form 8-K - Current report
3/06/202415:05GLOBESoleno Therapeutics Provides Corporate Update and Reports..
2/22/202407:00GLOBESoleno Therapeutics to Present at the TD Cowen 44th Annual..
1/31/202415:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/30/202415:57EDGAR2Form 8-K - Current report
1/29/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
1/24/202407:00GLOBESoleno Therapeutics Strengthens Leadership Team with Key..
1/17/202415:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/08/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:16EDGAR2Form 8-K - Current report
1/05/202407:00GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
1/02/202415:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
12/15/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202318:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202316:09EDGAR2Form 144 - Report of proposed sale of securities
12/13/202320:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202320:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202315:53EDGAR2Form 144 - Report of proposed sale of securities
12/13/202315:46EDGAR2Form 144 - Report of proposed sale of securities
12/12/202317:17EDGAR2Form 144 - Report of proposed sale of securities
12/11/202318:05EDGAR2Form 144 - Report of proposed sale of securities
12/04/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202315:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
11/07/202307:00GLOBESoleno Therapeutics Provides Corporate Update and Reports..
11/06/202307:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
10/31/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/20/202315:32EDGAR2Form S-3 - Registration statement under Securities Act of..
10/16/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10/12/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/11/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10/10/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/04/202317:16GLOBECorrecting & Replacing -- Soleno Therapeutics Announces DCCR..
10/04/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202315:05GLOBESoleno Therapeutics Announces DCCR Data Presentation at the..

Your Recent History

NASDAQ
SLNO
Soleno Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved